celecoxib 100 MG Oral Capsule [Celebrex]
- RxCUI
- 213468
- RxNorm name
- celecoxib 100 MG Oral Capsule [Celebrex]
- Display name
- CeleBREX (Oral Pill)
- Full name
- celecoxib 100 MG Oral Capsule [Celebrex]
- Term type
- SBD
- Status
- Active
- Strength
- 100 mg
- Dose form
- Cap
- Route
- Oral Pill
- Updated
- 2026-11-14 08:24:39
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| celecoxib | 100 MG / 1 EACH | celecoxib | celecoxib |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| celecoxib | 140587 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | CeleBREX 100 MG Oral Capsule | 1 | NAMES |
| RxNorm Name | celecoxib 100 MG Oral Capsule [Celebrex] | 1 | NAMES |
| RxNorm Synonym | Celebrex 100 MG Oral Capsule | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2d6675e4-5859-4be2-8037-a20ce9f707aa | 1 | CODES |
| RxCUI | 213468 | 1 | CODES |
| MMSL_CODE | BD6864 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 58151-083-01 | 58151-083 | CELEBREX Celecoxib | Viatris Specialty LLC | NDA020998 |
| 58151-083-05 | 58151-083 | CELEBREX Celecoxib | Viatris Specialty LLC | NDA020998 |
| 58151-083-88 | 58151-083 | CELEBREX Celecoxib | Viatris Specialty LLC | NDA020998 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Celecoxib | CELECOXIB | Advanced Rx Pharmacy of Tennessee, LLC | c8ade384-2072-2cc2-e053-2a95a90ae791 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 80425016702 |
| CELEBREX | CELECOXIB | Viatris Specialty LLC | 2d6675e4-5859-4be2-8037-a20ce9f707aa | 2024-11-22 | Boxed warning, Warnings, Adverse reactions | 58151-083-05 58151-083-88 58151-083-01 58151-083 58151008301 58151008388 58151008305 213468 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2aea0f50-b823-42ba-ab13-b40168bd55a2 | CeleBREX 100 MG Oral Capsule [PSN] · celecoxib 100 MG Oral Capsule [Celebrex] [SBD] · Celebrex 100 MG Oral Capsule [SY] | 3 | 3247 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | 20170320 |
| 2d6675e4-5859-4be2-8037-a20ce9f707aa | CeleBREX 100 MG Oral Capsule [PSN] · celecoxib 100 MG Oral Capsule [Celebrex] [SBD] · Celebrex 100 MG Oral Capsule [SY] | 3 | 13 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998 | 20241122 |
| 73eb9256-dcda-4eb1-8a6e-700522146f2e | CeleBREX 100 MG Oral Capsule [PSN] · celecoxib 100 MG Oral Capsule [Celebrex] [SBD] · Celebrex 100 MG Oral Capsule [SY] | 3 | 5 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | 20150505 |
| 925b0408-2ba4-4d4c-a1cd-ddfa7115234d | CeleBREX 100 MG Oral Capsule [PSN] · celecoxib 100 MG Oral Capsule [Celebrex] [SBD] · Celebrex 100 MG Oral Capsule [SY] | 3 | 3 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | 20120127 |
| b6bd0101-ebf0-43e8-99bf-21cb032b05d6 | CeleBREX 100 MG Oral Capsule [PSN] · celecoxib 100 MG Oral Capsule [Celebrex] [SBD] · Celebrex 100 MG Oral Capsule [SY] | 3 | 3 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | 20111214 |
| 0dcc7017-31c2-4979-ad33-2dc7f7a53d43 | CeleBREX 100 MG Oral Capsule [PSN] · celecoxib 100 MG Oral Capsule [Celebrex] [SBD] · Celebrex 100 MG Oral Capsule [SY] | 3 | 2 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | 20131107 |
| e3591a83-fbb4-4679-89f0-ce3a2331ed54 | CeleBREX 100 MG Oral Capsule [PSN] · celecoxib 100 MG Oral Capsule [Celebrex] [SBD] · Celebrex 100 MG Oral Capsule [SY] | 3 | 2 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | 20110513 |
| 14e50e10-bbe0-4a2c-983a-19bfa79bdef7 | CeleBREX 100 MG Oral Capsule [PSN] · celecoxib 100 MG Oral Capsule [Celebrex] [SBD] · Celebrex 100 MG Oral Capsule [SY] | 3 | 1 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | 20090710 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| c8ade384-2072-2cc2-e053-2a95a90ae791 | Celecoxib Capsules | Advanced Rx Pharmacy of Tennessee, LLC | 20241231 |
| 2d6675e4-5859-4be2-8037-a20ce9f707aa | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998 | Viatris Specialty LLC | 20241122 |
| 2e1b6011-d3c7-63a0-e054-00144ff88e88 | CELECOXIB | Direct_Rx | 20230418 |
| 29712b18-c82e-4397-800f-e2920f406f29 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998 | PD-Rx Pharmaceuticals, Inc. | 20220311 |
| 8d52185d-421f-4e34-8db7-f7676db2a226 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998 | PFIZER LABORATORIES DIV PFIZER INC | 20210415 |
| 2aea0f50-b823-42ba-ab13-b40168bd55a2 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | Lake Erie Medical DBA Quality Care Products LLC | 20170320 |
| 0dcc7017-31c2-4979-ad33-2dc7f7a53d43 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | Dispensing Solutions, Inc. | PSS World Medical, Inc. | 20131107 |
| c5c2445c-69a8-4cdc-83ff-eb379b8b4da1 | National Council for Prescription Drug Programs | 20130401 | |
| 33d3e061-8f2b-4fde-bf0b-8f2204f9240e | National Council for Prescription Drug Programs | 20130213 | |
| 92eda0a0-f458-470f-adb5-2242483e019b | National Council for Prescription Drug Programs | 20130213 | |
| cb5205aa-8fe7-4d9e-b50b-fc647ab374d5 | National Council for Prescription Drug Programs | 20120724 | |
| 9e9c9cdf-f650-4cd8-b37e-b0ec692ef90e | National Council for Prescription Drug Programs | 20120724 | |
| a0469ef8-819b-4d31-ade1-df0bbad6b7a0 | National Council for Prescription Drug Programs | 20120724 | |
| b30b7c93-68b0-49fb-b5d1-938e7d18a8b5 | National Council for Prescription Drug Programs | 20120724 | |
| b7e1043c-5acd-4ee4-9e80-c09c6cb565e2 | National Council for Prescription Drug Programs | 20120724 | |
| bae88ff1-2487-4fb3-a4f3-494f26285627 | National Council for Prescription Drug Programs | 20120724 | |
| 0af171e9-1d43-4306-8bd4-b337dcc3e410 | National Council for Prescription Drug Programs | 20120724 | |
| 98405925-9bf1-43e3-9944-c3eced362f42 | National Council for Prescription Drug Programs | 20120724 | |
| e595cc3e-6d1b-45f0-940e-926705d26d43 | National Council for Prescription Drug Programs | 20120724 | |
| ea04f1c4-4f1d-46ad-829a-fb42fa8c3369 | National Council for Prescription Drug Programs | 20120724 | |
| edc5e31c-0363-4f3e-9efa-63b4a426567d | National Council for Prescription Drug Programs | 20120724 | |
| f1ac37b6-2a2a-4529-bf75-8253a3cb1c84 | National Council for Prescription Drug Programs | 20120724 | |
| f392f54f-f489-4b27-8506-a739ecece1ba | National Council for Prescription Drug Programs | 20120724 | |
| fbdde64f-e276-498c-91bf-11f87188ea94 | National Council for Prescription Drug Programs | 20120724 | |
| 2c981af0-717f-491d-a04b-e56198d9f7e0 | National Council for Prescription Drug Programs | 20120724 | |
| 88212cb7-18af-4abc-b464-f87dbdc05b2c | National Council for Prescription Drug Programs | 20120724 | |
| 82938230-6211-46db-a5d7-cc9078dd4c2f | National Council for Prescription Drug Programs | 20120724 | |
| 7d3c184e-9ace-4496-afe4-68f484cb3ca1 | National Council for Prescription Drug Programs | 20120724 | |
| 77749cbb-3179-4838-b773-438d6cd8471e | National Council for Prescription Drug Programs | 20120724 | |
| 5f8c52f5-2648-496b-ace2-946d2387ca5a | National Council for Prescription Drug Programs | 20120724 | |
| 56da9962-4675-41be-a1f9-ba79703b7f7b | National Council for Prescription Drug Programs | 20120724 | |
| 4fc45240-4de0-4fed-a923-354ac5453e68 | National Council for Prescription Drug Programs | 20120724 | |
| 4e3b8f8b-a059-4c49-8d8c-dfded331d3b2 | National Council for Prescription Drug Programs | 20120724 | |
| 4c9acb7e-ca74-4e36-af6f-41810f2d8fc1 | National Council for Prescription Drug Programs | 20120724 | |
| 3bc93fc0-8ec4-49eb-9cd8-aca6b482b675 | National Council for Prescription Drug Programs | 20120724 | |
| 2364d3cd-b43f-475a-a1b8-a99cbab87686 | National Council for Prescription Drug Programs | 20120724 | |
| 925b0408-2ba4-4d4c-a1cd-ddfa7115234d | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | STAT Rx USA LLC | PSS World Medical Inc | 20120127 |
| b6bd0101-ebf0-43e8-99bf-21cb032b05d6 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | H.J. Harkins Company, Inc. | G.D. Searle LLC Division of Pfizer Inc | Pfizer Pharmaceuticals LLC | Pfizer Asia Pacific PTE LTD | 20111214 |
| e3591a83-fbb4-4679-89f0-ce3a2331ed54 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | STAT RX USA LLC | 20110513 |
| 14e50e10-bbe0-4a2c-983a-19bfa79bdef7 | These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998 | Rebel Distributors Corp. | 20090710 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | M01AH | Coxibs | ATC1-4 | celecoxib | |
| ATC | L01XX | Other antineoplastic agents | ATC1-4 | celecoxib | |
| FDASPL | N0000175722 | Nonsteroidal Anti-inflammatory Drug | EPC | has_epc | celecoxib |
| FDASPL | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | celecoxib |
| MEDRT | D000068579 | Celecoxib | CHEM | has_ingredient | celecoxib |
| MEDRT | D011125 | Adenomatous Polyposis Coli | DISEASE | may_treat | celecoxib |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | celecoxib |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | celecoxib |
| MEDRT | D004412 | Dysmenorrhea | DISEASE | may_treat | celecoxib |
| MEDRT | D010003 | Osteoarthritis | DISEASE | may_treat | celecoxib |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | celecoxib |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | celecoxib |
| MEDRT | N0000008288 | Cyclooxygenase 2 Inhibitors | MOA | has_moa | celecoxib |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | celecoxib |
| MEDRT | N0000000045 | Fecal Excretion | PK | has_pk | celecoxib |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | celecoxib |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | celecoxib |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 100 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA020998 |
| NAMES | Prescribable Synonym | CeleBREX 100 MG Oral Capsule |
| NAMES | Tallman Synonym | CeleBREX 100 MG Oral Capsule |
| NAMES | Tallman Synonym | celecoxib 100 MG Oral Capsule [CeleBREX] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |